Press Room

Osstell to Investigate Possible Patent Infringement

 

Gothenburg, October 16, 2015 Osstell has initiated an investigation of possible infringement on Osstell’s proprietary and patented ISQ technology using Resonance Frequency Analysis (RFA). The process seeks to primarily clarify and verify unauthorized use of Osstell’s patented technology, and to possibly recover damages caused by the infringement.

 

Osstell has discovered that a product is being marketed that claims to measure ISQ on dental implants. According to its documentation and the claims made by the staff of the company, it seems to infringe on Osstell’s proprietary technology, patented by Osstell. Read More >

 

 

Osstell Presents New Platform For Objective Implant Stability Assessment

 

Gothenburg (Sweden), March 10, 2015: Osstell, the company that developed the ISQ technology, is today launching the Osstell IDx – a completely new and improved platform with a novel, intuitive user interface and functional design. The Osstell IDx is combined with the new Osstell Connect – a set of online services for automatic ISQ data storage, sharing and analysis of implant stability data.

 

Osstell now takes the next leap in the evolution of implant diagnostics with the introduction of Osstell IDx. It displays the ISQ measurements in an intuitive and easily interpreted way. It is easier than ever to assess implant stability and the degree of osseointegration, ensuring that implants are stable enough for final restoration. It also facilitates the communication with patients, or the restorative dentists, concerning the treatment plans. Read More >

Osstell is Proud to Present Its New Distribution Partner Unident

 

Gothenburg (Sweden), October 1, 2014Unident is now the official distribution partner of Osstell products on the dental implant markets in Sweden, Norway, Denmark and Finland.

 

Osstell instruments make it possible to monitor osseointegration in a precise and objective manner, as one of the most important factors for a successful implant treatment is the stability of the implant. The main advantages of using Osstell diagnostics are reduced treatment time and the ability to manage implants at risk. Read More >

Sign up to our press list to receive the latest news from Osstell.

 

[gravityform id=”9″ title=”false” description=”false”]

For any press related inquiries, please contact

 

Lina Sanner

Lina Sanner

Global Marketing Director
lina.sanner@osstell.com


Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home/u/u0439467/www/osstell-dev/wp-includes/functions.php on line 3653